Endoscopic management of recurrent pancreatitis

Abstract

Endoscopic therapy is a well-established, valuable alternative to surgery for the treatment of a variety of biliary tract diseases. Applications of similar techniques to the pancreas continue to develop. Encouraged by the recognition of the relative safety of ERCP and endoscopic sphincterotomy (ES) for gallstone pancreatitis, endoscopic therapy is now being applied in the setting of acute pancreatitis of other etiologies, chronic pancreatitis, complications of acute or chronic pancreatitis, and pancreas divisum.

Key words

Endoscopic sphincterotomy - pancreas divisum - recurrent pancreatitis

• References

• 1 Fischer M, Hassan A, Sipe BW, Fogel EL, McHenry L, Sherman S, et al. Endoscopic retrograde cholangiopancreatography and manometry findings in 1,241 idiopathic pancreatitis patients. Pancreatology 2010;10:444-52.
• 2 Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PDR, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012;366:1414-22.
• 3 Cahen DL, Gouma DJ, Laramee P, Nio Y, Rauws EA, Boermeester MA, et al. Long-term outcomes of endoscopic vs. surgical drainage of the pancreatic duct in patients with chronic pancreatitis. Gastroenterology 2011;141:1690-5.
• 4 Choi EK, Lehman GA. Update on endoscopic management of main pancreatic duct stones in chronic calcific pancreatitis. Korean J Intern Med 2012;27:20-9.
• 5 Bertin C, Pelletier AL, Vullierme MP, Bienvenu T, Rebours V, Hentic O, et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am J Gastroenterol 2012;107:311-7.
• 6 Choudari, CP, Imperiale TF, Sherman S, Fogel E, Lehman GA. Risk of pancreatitis with mutation of the cystic fibrosis gene. Am J Gastroenterol 2004;99:1358-63.